Source: International Congress 2014 – Critical illness and therapeutic interventions
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. R. Holger, K. Ute, T. Tschernig, S. Wienhold, M. Polikarpova, K. Hellwig, A. Vater, C. Maasch, S. Klussmann, M. Menger, N. Suttorp, M. Witzenrath (Berlin, Homburg, Germany). Neutralizing the complement component C5a protects against lung injury and extrapulmonary organ injury in pneumococcal pneumonia induced sepsis. Eur Respir J 2014; 44: Suppl. 58, 1385

Member's Comments

No comment yet.

Related content which might interest you: Methotrexate reduces acute lung injury in a murine model of sepsis Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism Year: 2016 Salmeterol prevents pneumonia and reduces biomarkers of inflammation/epithelial damage but not acute lung injury following oesophagectomy-the results of BALTI-prevention trial Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights Year: 2013 Ventilator-induced lung injury in severe pneumococcal pneumonia: Protection by adrenomedullin Source: Annual Congress 2012 - Novel mechanisms of acute lung injury Year: 2012 Effects of nebulized heparin on pulmonary inflammation in a rat model of acute lung injury Source: International Congress 2015 – Acute critical care: novelties in critical care Year: 2015 Acute respiratory failure and severe sepsis may identify different clinical phenotypes in community-acquired pneumonia Source: Annual Congress 2013 –Interesting research questions Year: 2013 Neutrophilia is associated with the persistent parenchymal changes after acute lung injury Source: International Congress 2015 – Latest insights into chronic care Year: 2015 CD4 as a predictor of systemic inflammatory response and death at severe community-acquired pneumonia Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013 Arterial oxygen content could reflect acute organ damage in community-acquired pneumonia Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014 Vasculotide reduced pulmonary hyperpermeability in pneumococcal pneumonia Source: International Congress 2016 – Translational research in respiratory infections Year: 2016 Acute lung injury and ventilator-associated pneumonia: introduction Source: Eur Respir J 2003; 22: 1S Year: 2003 A mouse model of acute lung injury implicates phospholipase Cε in neutrophilic inflammation through CXC chemokine production Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair Year: 2016 Down-regulation of RIP140 can prevent LPS-induced inflammation and acute lung injury in mice via PPARγ Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury Year: 2015 Respiratory pathogens, immunodeficiency or systemic response – What comes first in the etiology of severe community-acquired pneumonia (sCAP) Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Oral inhalation of AP301 peptide activates pulmonary oedema clearance: Initial results from a phase IIa clinical trial in mechanically ventilated ICU patients Source: International Congress 2014 – Critical illness and therapeutic interventions Year: 2014 Snake venom leads to injury similar to acute lung injury revealing the needing of anti-inflammatory therapy Source: Annual Congress 2013 –The pulmonary epithelium: recent developments Year: 2013 Smoking status and respiratory infections during mechanical ventilation Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment Year: 2013 Proton-sensing TDAG8 exhibits the protective role in lipopolysaccharide-induced acute lung injury Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair Year: 2016 The role of SIRT1 in LPS-induced lung endothelial barrier dysfunction and lung injury in vivo Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Comparison of reducing effect on lung injury of dexamethasone and bosentan in acute lung injury: An experimental study Source: International Congress 2014 – Experimental models in acute lung injury Year: 2014 LATE-BREAKING ABSTRACT: Human mesenchymal stem cell exosomes attenuates sepsis-induced acute lung injury via inhibition of oxidative stress and the MAPK-NF-?B pathway Source: International Congress 2015 – Acute critical care: mechanical ventilation: how to limit the damage Year: 2015